Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
https://www.bloomberg.com/news/articles/2023-01-13/pfizer-bivalent-vaccine-linked-to-stroke-in-preliminary-data?srnd=premium-europe
Time for a new approach ?
Konar. -very unlikely as the the trial participants had previously shared her fantastic results on social media for all to see.
Scancell only commented on the result after they had been asked for clarification from shareholders.
JM50. I see you have only signed up to this website today,
There are a few on here that may be suspicious of new posters, but I’m sure you won’t be one of the returning banned posters so let me be the first to welcome you and your insights.
Looking forward to you
If the current cohort is turning out exceptional results ( and going by all publicly available information, it is !)
Then it might make sense to concentrate on what is working better than all currently available options?
I must admit I'm quite surprised at the low share price considering the unofficial updates we have had from the first patient on the macmillan website.
We have been told by the company that they are genuine and they have posted that they have had over 50 % tumor reduction after only a couple of months and only halfway through their treatment.
It would be very, very unlikely that patient one is the only one to respond this way, my feeling is that this result will be repeated and reported very soon.
Well done scancell and all the best to the patients.